Edinburgh-based Resolution Therapeutics appointed Paul Sekhri as chair, replacing Lisa Bright.
PharmaCambridge Innovation Capital: Carol Cheung
Cambridge Innovation Capital (CIC) has appointed Carol Cheung as principal within the CIC investment team.
Since joining CIC in 2016, Cheung has been responsible for managing CIC’s investments in to the technology companies, Cytora and Geospock.
Prior to joining CIC, Cheung served as commercial director of speechmatics, a Cambridge-based start-up providing cloud-based speech recognition.
Cheung holds an MBA from the University of Cambridge and is a CFA charterholder.
Commenting on her new role, Cheung said: “I am thrilled to be taking on this new role within CIC. It’s been nothing short of fantastic working with the team so far to find, build and shape world-leading companies linked to the Cambridge ecosystem, and I am looking forward to the myriad of exciting opportunities heading our way in the near future.”
Andrew Williamson, managing partner of CIC, commented: “Carol has proven herself to be an invaluable member of the CIC team over the past four years. Carol’s promotion reflects the significant contribution she has made to the ongoing success of CIC, and we are very excited to see what she will achieve in her new role.”
Latest Executive Moves
Broken String Biosciences, has appointed Laurence Reid as chairman, and Brad Crutchfield as a non-executive director.
PharmaCare home provider Signature Senior Lifestyle has appointed Vishul Seewoolall as chief operating officer.
Social care